We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$309B
AUM Growth
+$12.1B
Cap. Flow
+$28.2B
Cap. Flow %
9.12%
Top 10 Hldgs %
39.73%
Holding
9,820
New
1,242
Increased
3,523
Reduced
3,660
Closed
1,288

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.11B
2
AAPL icon
Apple
AAPL
+$2.02B
3
MSFT icon
Microsoft
MSFT
+$612M
4
AMZN icon
Amazon
AMZN
+$554M
5
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$420M

Sector Composition

Rank Sector Weight
1 Technology 2.61%
2 Consumer Discretionary 1.65%
3 Financials 1.07%
4 Healthcare 1.03%
5 Communication Services 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EIGR
8351
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.49K ﹤0.01%
491
-716
-59% -$14.4K
MTNB icon
8352
Matinas BioPharma
MTNB
$1.81M
$4.49K ﹤0.01%
+690
New +$8.47K
PHUN icon
8353
Phunware
PHUN
$43.6M
$4.48K ﹤0.01%
501
+88
+21% +$1.46K
AILEW
8354
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$4.36K ﹤0.01%
24,230
MBTCR
8355
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$4.34K ﹤0.01%
27,758
-100
-0.4% -$18
AMTI
8356
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$4.21K ﹤0.01%
+26,818
New +$7.13K
ADEX.WS
8357
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$4.15K ﹤0.01%
69,099
-62
-0.1% -$5
TRCA.WS
8358
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$4.07K ﹤0.01%
54,223
ADXN
8359
Addex Therapeutics
ADXN
$7.34M
$4.07K ﹤0.01%
+529
New +$5.33K
ABVEW
8360
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$3.93K ﹤0.01%
97,772
+84
+0.1% +$6
CCVI.WS
8361
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$3.92K ﹤0.01%
27,756
-66
-0.2% -$12
OSI.WS
8362
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$3.65K ﹤0.01%
120,849
ZOM
8363
DELISTED
Zomedica Corp.
ZOM
$3.61K ﹤0.01%
21,602
-234,235
-92% -$45.5K
QDROW
8364
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$3.48K ﹤0.01%
69,658
PDYNW icon
8365
Palladyne AI Corp Warrants
PDYNW
$156K
$3.38K ﹤0.01%
197,345
STIXW
8366
DELISTED
Semantix, Inc. Warrant
STIXW
$3.37K ﹤0.01%
80,042
CFIVW
8367
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$3.33K ﹤0.01%
66,600
AVTX icon
8368
Avalo Therapeutics
AVTX
$983M
$3.32K ﹤0.01%
+115
New +$5.14K
MBAC.WS
8369
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$3.31K ﹤0.01%
73,475
-106
-0.1% -$5
PRENW
8370
Prenetics Global Ltd Warrant
PRENW
$161K
$3.31K ﹤0.01%
82,647
XOSWW
8371
Xos Inc Warrants
XOSWW
$12.2K
$3.3K ﹤0.01%
117,756
+1,078
+0.9% +$44
ONCT
8372
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$3.09K ﹤0.01%
514
-548
-52% -$3.86K
ACRO.WS
8373
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$3.07K ﹤0.01%
51,095
CSTA.WS
8374
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$2.97K ﹤0.01%
110,394
-122
-0.1% -$5
XTIA icon
8375
XTI Aerospace
XTIA
$58.9M
$2.76K ﹤0.01%
1
-1
-50% -$4.19K

Similar funds

Jane Street's Q3 2023 Portfolio in Review

As of Q3 2023, Jane Street held 9,820 positions worth $309B, up 4.1% from $297B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Jane Street deployed $28.2B of net new capital in Q3 2023, opening 1,242 new positions and adding to 3,523 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.

By sector, the portfolio is most concentrated in Technology at 2.6% of assets, down from 4% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Tesla, an estimated $2.11B trimmed.

  • Jane Street's largest Q3 2023 buy was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $6.24B increase.
  • Jane Street's biggest Q3 2023 reduction was Tesla, cutting an estimated $2.11B.
  • Jane Street fully exited iShares Silver Trust in Q3 2023, selling an estimated $130M.
  • Jane Street's ten largest holdings make up 40% of its $309B portfolio in Q3 2023.
  • Jane Street opened 1,242 new positions and closed 1,288 in Q3 2023.
  • Jane Street's portfolio value rose 4.1% quarter-over-quarter to $309B.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.